ICYMI: I-MAK: Cracking Down on Big Pharma’s Patent Abuse to Lower Drug Prices Should Be Bipartisan Priority
Non-Profit Advocates for Affordable Prescription Drug Prices Call on Congress to Increase Competition and Hold Big Pharma Accountable In case you missed it, Tahir Amin and Priti Krishtel, co-executive directors of the Initiative for Medicines, Access & Knowledge (I-MAK), published an op-ed in The Hill calling on Congress to lower prescription drug prices by holding